USD 0.0
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 164 Thousand USD | 0.0% |
2022 | 164 Thousand USD | -48.85% |
2021 | 320.61 Thousand USD | -60.1% |
2020 | 803.61 Thousand USD | 0.0% |
2019 | 803.61 Thousand USD | 0.0% |
2018 | 803.61 Thousand USD | 0.0% |
2017 | 803.61 Thousand USD | 11.06% |
2016 | 723.61 Thousand USD | -0.0% |
2015 | 723.61 Thousand USD | 0.0% |
2014 | 723.61 Thousand USD | 0.0% |
2013 | 723.61 Thousand USD | 0.0% |
2012 | 723.61 Thousand USD | -0.34% |
2011 | 726.05 Thousand USD | -3.96% |
2010 | 756.02 Thousand USD | 54.37% |
2009 | 489.75 Thousand USD | 70673.7% |
2008 | 692.00 USD | -98.36% |
2007 | 42.19 Thousand USD | -97.17% |
2006 | 1.49 Million USD | -20.03% |
2005 | 1.86 Million USD | 254.58% |
2004 | 525.59 Thousand USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q3 | 164 Thousand USD | 0.0% |
2024 Q2 | 164 Thousand USD | 0.0% |
2024 Q1 | 164 Thousand USD | 0.0% |
2023 Q1 | 164 Thousand USD | 0.0% |
2023 Q4 | 164 Thousand USD | 0.0% |
2023 Q2 | 164 Thousand USD | 0.0% |
2023 FY | 164 Thousand USD | 0.0% |
2023 Q3 | 164 Thousand USD | 0.0% |
2022 Q1 | 320.61 Thousand USD | 0.0% |
2022 Q2 | 164 Thousand USD | -48.85% |
2022 Q3 | 164 Thousand USD | 0.0% |
2022 FY | 164 Thousand USD | -48.85% |
2022 Q4 | 164 Thousand USD | 0.0% |
2021 Q3 | 320.61 Thousand USD | -60.1% |
2021 Q4 | 320.61 Thousand USD | 0.0% |
2021 FY | 320.61 Thousand USD | -60.1% |
2021 Q1 | 803.61 Thousand USD | 0.0% |
2021 Q2 | 803.61 Thousand USD | 0.0% |
2020 Q4 | 803.61 Thousand USD | 0.0% |
2020 Q1 | 803.61 Thousand USD | 0.0% |
2020 Q2 | 803.61 Thousand USD | 0.0% |
2020 Q3 | 803.61 Thousand USD | 0.0% |
2020 FY | 803.61 Thousand USD | 0.0% |
2019 Q3 | 803.61 Thousand USD | 0.0% |
2019 FY | 803.61 Thousand USD | 0.0% |
2019 Q2 | 803.61 Thousand USD | 0.0% |
2019 Q4 | 803.61 Thousand USD | 0.0% |
2019 Q1 | 803.61 Thousand USD | 0.0% |
2018 Q4 | 803.61 Thousand USD | 0.0% |
2018 FY | 803.61 Thousand USD | 0.0% |
2018 Q3 | 803.61 Thousand USD | 0.0% |
2018 Q2 | 803.61 Thousand USD | 0.0% |
2018 Q1 | 803.61 Thousand USD | 0.0% |
2017 Q3 | 803.61 Thousand USD | 6.63% |
2017 Q1 | 723.61 Thousand USD | 0.0% |
2017 FY | 803.61 Thousand USD | 11.06% |
2017 Q4 | 803.61 Thousand USD | 0.0% |
2017 Q2 | 753.61 Thousand USD | 4.15% |
2016 Q1 | 723.61 Thousand USD | 0.0% |
2016 Q4 | 723.61 Thousand USD | 0.0% |
2016 Q3 | 723.61 Thousand USD | -0.0% |
2016 Q2 | 723.61 Thousand USD | 0.0% |
2016 FY | 723.61 Thousand USD | -0.0% |
2015 Q2 | 723.61 Thousand USD | 0.0% |
2015 Q1 | 723.61 Thousand USD | 0.0% |
2015 Q4 | 723.61 Thousand USD | 0.0% |
2015 FY | 723.61 Thousand USD | 0.0% |
2015 Q3 | 723.61 Thousand USD | 0.0% |
2014 Q1 | 723.61 Thousand USD | 0.0% |
2014 Q3 | 723.61 Thousand USD | 0.0% |
2014 Q4 | 723.61 Thousand USD | 0.0% |
2014 FY | 723.61 Thousand USD | 0.0% |
2014 Q2 | 723.61 Thousand USD | 0.0% |
2013 Q4 | 723.61 Thousand USD | 0.0% |
2013 FY | 723.61 Thousand USD | 0.0% |
2013 Q3 | 723.61 Thousand USD | 0.0% |
2013 Q2 | 723.61 Thousand USD | 0.0% |
2013 Q1 | 723.61 Thousand USD | 0.0% |
2012 Q1 | 722.05 Thousand USD | -0.55% |
2012 Q4 | 723.61 Thousand USD | -0.62% |
2012 FY | 723.61 Thousand USD | -0.34% |
2012 Q3 | 728.11 Thousand USD | 0.0% |
2012 Q2 | 728.11 Thousand USD | 0.84% |
2011 Q3 | 739.58 Thousand USD | 5.58% |
2011 Q4 | 726.05 Thousand USD | -1.83% |
2011 FY | 726.05 Thousand USD | -3.96% |
2011 Q1 | 743.68 Thousand USD | -1.63% |
2011 Q2 | 700.49 Thousand USD | -5.81% |
2010 Q1 | 472.83 Thousand USD | -3.46% |
2010 Q2 | 788.01 Thousand USD | 66.66% |
2010 Q4 | 756.02 Thousand USD | -13.78% |
2010 FY | 756.02 Thousand USD | 54.37% |
2010 Q3 | 876.88 Thousand USD | 11.28% |
2009 Q2 | 321.81 Thousand USD | 26.55% |
2009 Q4 | 489.75 Thousand USD | 34.21% |
2009 FY | 489.75 Thousand USD | 70673.7% |
2009 Q1 | 254.3 Thousand USD | 36648.7% |
2009 Q3 | 364.9 Thousand USD | 13.39% |
2008 Q2 | 19.78 Thousand USD | 0.0% |
2008 FY | 692.00 USD | -98.36% |
2008 Q1 | 19.78 Thousand USD | -53.12% |
2008 Q3 | 649.2 Thousand USD | 3182.1% |
2008 Q4 | 692.00 USD | -99.89% |
2007 Q4 | 42.19 Thousand USD | -66.78% |
2007 Q3 | 126.99 Thousand USD | -17.81% |
2007 Q2 | 154.51 Thousand USD | -90.03% |
2007 Q1 | 1.55 Million USD | 4.03% |
2007 FY | 42.19 Thousand USD | -97.17% |
2006 Q2 | 2.31 Million USD | 10.2% |
2006 Q1 | 2.09 Million USD | 12.56% |
2006 FY | 1.49 Million USD | -20.03% |
2006 Q4 | 1.49 Million USD | -41.79% |
2006 Q3 | 2.56 Million USD | 10.76% |
2005 Q4 | 1.86 Million USD | 48.32% |
2005 Q1 | 655.59 Thousand USD | 24.73% |
2005 Q3 | 1.25 Million USD | 27.12% |
2005 FY | 1.86 Million USD | 254.58% |
2005 Q2 | 988.45 Thousand USD | 50.77% |
2004 Q2 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 FY | 525.59 Thousand USD | 0.0% |
2004 Q4 | 525.59 Thousand USD | 0.0% |
2004 Q1 | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
American Medical Technologies Inc. | 500 Thousand USD | 67.2% |
Ansell Limited | 855.59 Million USD | 99.981% |
Ansell Limited | 857.2 Million USD | 99.981% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 22.41 Million USD | 99.268% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | 20.93 Thousand USD | -683.377% |
Psykey, Inc. | 1.01 Million USD | 83.772% |
ConvaTec Group Plc | 1.31 Billion USD | 99.987% |
ConvaTec Group Plc | 1.31 Billion USD | 99.988% |
Encision Inc. | 1.33 Million USD | 87.699% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | 2.3 Million USD | 92.896% |
Innovative MedTech Inc. | 1.87 Million USD | 91.268% |
LifePoint, Inc. | 446.74 Thousand USD | 63.29% |
Medite Cancer Diagnostics, Inc. | 5.39 Million USD | 96.96% |
Paradigm Medical Industries, Inc. | 2.18 Million USD | 92.508% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | - USD | -Infinity% |
Reflect Scientific, Inc. | 242.64 Thousand USD | 32.411% |
SmileDirectClub, Inc. | 871.79 Million USD | 99.981% |
Shandong Weigao Group Medical Polymer Company Limited | 674.01 Million USD | 99.976% |
SheerVision, Inc. | 75 Thousand USD | -118.667% |
United Health Products, Inc. | 755.98 Thousand USD | 78.307% |
Vasamed, Inc. | 23.45 Thousand USD | -599.36% |
Wearable Health Solutions, Inc. | 2.76 Million USD | 94.074% |
Yubo International Biotech Limited | 790.49 Thousand USD | 79.254% |